In this Episode, Dr. James S. Lewis from University of Texas Health Sciences Center in San Antonio, Texas provides insights on differentiation among newer agents for MRSA bacteremia and endocarditis.

Can we differentiate among newer agents for MRSA bacteremia and endocarditis?

Designed to clarify persistent issues in serious MRSA infections that pose 
a threat to patient safety and add to the healthcare burden. Experts answer frequently asked questions and share their own clinical experience. This activity consists of 20 episodes that will be released weekly beginning October 4, 2010.

Education

Designed to clarify persistent issues in serious MRSA infections that pose a threat to patient safety and add to the healthcare burden. Experts answer frequently asked questions and share their own clinical experience. This activity consists of 20 episodes that will be released weekly beginning October 4, 2010.

Share Can we differentiate among newer agents for MRSA bacteremia and endocarditis?

Sign up to save your podcasts

Can we differentiate among newer agents for MRSA bacteremia and endocarditis?

Can we differentiate among newer agents for MRSA bacteremia and endocarditis?

More shows like Let's Talk MRSA: 20 Frequently Asked Questions

ASHPOfficial